Completed NA INTERVENTIONAL 4-arm NCT04558190

Mitochondrial Dysfunction and Insulin Resistance in Skeletal Muscle

Sponsor: University of Copenhagen

Interventions Intralipid, 20% Intravenous Emulsion MitoQ Salbutamol

Updated 5 times since 2020 Last updated: Dec 1, 2021 Started: Sep 2, 2020 Primary completion: Nov 1, 2021 Completion: Nov 1, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04558190, this NA trial focuses on Insulin Resistance and remains completed. Sponsored by University of Copenhagen, it has been updated 5 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2022 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Jan 2021 — Jan 2022 [monthly]

Recruiting NA
Oct 2020 — Jan 2021 [monthly]

Recruiting NA

First recorded

Sep 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Copenhagen

Data source: University of Copenhagen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Copenhagen, Denmark